1. m6A reader IGF2BP1 reduces the sensitivity of nasopharyngeal carcinoma cells to Taxol by upregulation of AKT2
   Chong Zhao et al, 2024, Anti-Cancer Drugs CrossRef
2. A narrative review of the role of Eph receptors in head and neck squamous cell carcinoma
   Aisha A. H. Al‐Jamaei et al, 2023, Oral Diseases CrossRef
3. Targeting EphA2: a promising strategy to overcome chemoresistance and drug resistance in cancer
   Rafaela Nasser Veiga et al, 2024, Journal of Molecular Medicine CrossRef
4. Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells
   Francesca Megiorni et al, 2017, Journal of Hematology & Oncology CrossRef
5. PI3K‐PKB‐mTOR hyperactivation in relation to nasopharyngeal carcinoma progression and prognosis
   Jian‐Hua Yu et al, 2019, Journal of Cellular Biochemistry CrossRef
6. Mechanisms of Taxane Resistance
   Sara M. Maloney et al, 2020, Cancers CrossRef
7. Expression Pattern and Prognostic Value of EPHA/EFNA in Breast Cancer by Bioinformatics Analysis: Revealing Its Importance in Chemotherapy
   Zheng Liang et al, 2021, BioMed Research International CrossRef
8. Eph signal inhibition potentiates the growth-inhibitory effects of PLK1 inhibition toward cancer cells
   Ryuzaburo Yuki et al, 2024, European Journal of Pharmacology CrossRef
9. Discovery of novel cell-penetrating and tumor-targeting peptide-drug conjugate (PDC) for programmable delivery of paclitaxel and cancer treatment
   Xin Deng et al, 2021, European Journal of Medicinal Chemistry CrossRef
10. AZD4547 targets the FGFR/Akt/SOX2 axis to overcome paclitaxel resistance in head and neck cancer
    Abdulmelik Aytatli et al, 2022, Cellular Oncology CrossRef
11. Loss of H3K27 Trimethylation Promotes Radiotherapy Resistance in Medulloblastoma and Induces an Actionable Vulnerability to BET Inhibition
    Nishanth Gabriel et al, 2022, Cancer Research CrossRef